A detailed history of Capital Planning Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Capital Planning Advisors, LLC holds 14,513 shares of PFE stock, worth $387,787. This represents 0.07% of its overall portfolio holdings.

Number of Shares
14,513
Previous 14,319 1.35%
Holding current value
$387,787
Previous $397,000 2.27%
% of portfolio
0.07%
Previous 0.07%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$25.26 - $29.6 $4,900 - $5,742
194 Added 1.35%
14,513 $406,000
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $4,789 - $5,500
185 Added 1.31%
14,319 $397,000
Q4 2023

Feb 12, 2024

SELL
$26.13 - $33.94 $58,060 - $75,414
-2,222 Reduced 13.59%
14,134 $406,000
Q3 2023

Oct 30, 2023

BUY
$32.09 - $37.51 $8,503 - $9,940
265 Added 1.65%
16,356 $542,000
Q2 2023

Aug 01, 2023

BUY
$36.12 - $41.79 $10,149 - $11,742
281 Added 1.78%
16,091 $590,000
Q1 2023

May 15, 2023

SELL
$39.39 - $51.28 $80,907 - $105,329
-2,054 Reduced 11.5%
15,810 $645,000
Q4 2022

Feb 09, 2023

BUY
$41.75 - $54.5 $77,947 - $101,751
1,867 Added 11.67%
17,864 $915,000
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $38,465 - $46,956
-879 Reduced 5.21%
15,997 $700,000
Q2 2022

Aug 10, 2022

SELL
$46.53 - $55.17 $11,539 - $13,682
-248 Reduced 1.45%
16,876 $885,000
Q1 2022

May 10, 2022

BUY
$45.75 - $56.69 $1,418 - $1,757
31 Added 0.18%
17,124 $887,000
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $116,274 - $172,357
2,814 Added 19.71%
17,093 $1.01 Million
Q1 2021

Apr 30, 2021

BUY
$33.49 - $37.77 $7,099 - $8,007
212 Added 1.51%
14,279 $517,000
Q4 2020

Feb 04, 2021

SELL
$33.47 - $42.56 $96,728 - $122,998
-2,890 Reduced 17.04%
14,067 $518,000
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $39,624 - $46,488
-1,248 Reduced 6.86%
16,957 $622,000
Q2 2020

Aug 06, 2020

SELL
$30.12 - $36.54 $9,819 - $11,912
-326 Reduced 1.76%
18,205 $595,000
Q1 2020

May 11, 2020

SELL
$27.03 - $38.62 $15,974 - $22,824
-591 Reduced 3.09%
18,531 $605,000
Q4 2019

Feb 03, 2020

SELL
$32.92 - $37.36 $76,736 - $87,086
-2,331 Reduced 10.87%
19,122 $749,000
Q3 2019

Nov 05, 2019

SELL
$32.49 - $42.13 $357,032 - $462,966
-10,989 Reduced 33.87%
21,453 $771,000
Q2 2019

Aug 09, 2019

SELL
$36.98 - $41.52 $67,303 - $75,566
-1,820 Reduced 5.31%
32,442 $1.41 Million
Q1 2019

May 14, 2019

BUY
$37.5 - $41.2 $9,337 - $10,258
249 Added 0.73%
34,262 $1.46 Million
Q4 2018

Feb 13, 2019

SELL
$38.47 - $43.86 $104,253 - $118,860
-2,710 Reduced 7.38%
34,013 $1.49 Million
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $637,695 - $773,485
18,500 Added 101.52%
36,723 $1.62 Million
Q2 2018

Aug 08, 2018

SELL
$32.98 - $35.16 $1.21 Million - $1.29 Million
-36,731 Reduced 66.84%
18,223 $661,000
Q1 2018

May 15, 2018

SELL
$31.91 - $37.02 $234,602 - $272,171
-7,352 Reduced 11.8%
54,954 $1.95 Million
Q4 2017

Feb 08, 2018

SELL
$33.26 - $35.29 $495,041 - $525,256
-14,884 Reduced 19.28%
62,306 $2.26 Million
Q3 2017

Nov 09, 2017

BUY
$31.0 - $34.15 $2.39 Million - $2.64 Million
77,190
77,190 $2.76 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Capital Planning Advisors, LLC Portfolio

Follow Capital Planning Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Planning Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Planning Advisors, LLC with notifications on news.